 |
|
|
|
| Selected Reading |
 Achtman M, Morelli G, Zhu P, et al. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci 2004 Dec 21;101(51):17837-42 [Full text]
Achtman M, Zurth K, Morelli G, et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci 1999 Nov 23;96(24):14043-8 [Full text (Erratum in Proc Natl Acad Sci 2000 Jul 5;97(14):8192 - link on opening page of full text)]
ACIP/CDC. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR14):1-15 [Full text]
Airhart CL, Rohde HN, Bohach GA, et al. Induction of innate immunity by lipid A mimetics increases survival from pneumonic plague. Microbiology 2008 Jul;154(7):2131-8 [Abstract]
Alfsofrom DJ, Mettler FA Jr, Mann JM. Radiographic manifestations of plague in New Mexico, 1975-1980. A review of 42 proved cases. Radiology 1981;139(3):561-5
Allen JS, Skowera A, Rubin GJ, et al. Long-lasting T cell responses to biological warfare vaccines in human vaccinees. Clin Infect Dis 2006 Jul 1;43(1):1-7 [Abstract]
Alvarez ML, Pinyerd HL, Crisantes JD, et al. Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 2006 Mar 24;24(14):2477-90 [Abstract]
Anisimov AP, Lindler LE, Pier GB. Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev 2004 Apr;17(2):434-64 [Abstract]
Arbaji A, Kharabsheh S, Al-Azab S, et al. A 12-case outbreak of pharyngeal plague following the consumption of camel meat, in north-eastern Jordan. Ann Trop Med Parasitol 2005 Dec;99(8):789-93 [Abstract]
Arlen PA, Singelton M, Adamovicz JJ, et al. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun 2008 Aug;76(8):3540-50 [Abstract]
Ayyadurai S, Houhamdi L, Lepidi H, et al. Long-term persistence of virulent Yersinia pestis in soil. Microbiology 2008 Sep;154(pt 9):2865-71 [Abstract]
Balada-Llasat JM, Panilaitis B, Kaplan D, et al. Oral inoculation with type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia. Vaccine 2007 Feb 9;25(8):1526-33 [Abstract]
Bartra SS, Styer KL, O'Bryant DM, et al. Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect Immun 2008 Feb;76(2):612-22 [Abstract]
Bashaw J, Norris S, Weeks S, et al. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol 2007 May;14(5):605-16 [Abstract]
Begier EM, Asiki G, Anywaine Z, et al. Pneumonic plague cluster, Uganda, 2004. Emerg Infect Dis 2006 Mar;12(3):460-7 [Full text]
Begon M, Klassovskiy N, Ageyev V, et al. Epizootiologic parameters for plague in Kazakhstan. Emerg Infect Dis 2006 Feb;12(2):268-73 [Full text]
Ben Ari T, Gershunov A, Gage KL, et al. Human plague in the USA: the importance of regional and local climate. Biol Lett 2008 (published online Sep 2) [Abstract]
Bergsbaken T, Cookson BT. Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog 2007 Nov 2;3(11):e161 [Full text]
Bertherat E, Bekhoucha S, Chougrani S, et al. Plague reemergence in Algeria after 50 years, 2003. Emerg Infect Dis 2007 Oct;13(10):1459-62 [Full text]
Bitam I, Baziz B, Rolain J-M, et al. Zoonotic focus of plague, Algeria. Emerg Infect Dis 2006 Dec;12(12) (published online Nov 13) [Full text]
Blisnick T, Ave P, Huerre M, et al. Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain. Infect Immun 2008 Aug;76(8);3808-16 [Abstract]
Bonacorsi SP, Scavizzi MR, Guiyoule A, et al. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in the treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother 1994;38:481-6 [Abstract]
Boone A, Kraft JP, Stapp P. Scavenging by mammalian carnivores on prairie dog colonies: implications for the spread of plague. Vector-Borne Zoonotic Dis 2008 (published online Oct 22) [Abstract]
Boulanger LL, Ettestad P, Fogarty JD, et al. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985-1999. Clin Infect Dis 2004 Mar;38(5):663-9 [Abstract]
Bubeck SS, Cantwell AM, Dube PH. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun 2007 Feb;75(2):697-705 [Abstract]
Bubeck SS, Dube PH. Yersinia pestis CO92(delta)yopH is a potent live-attenuated plague vaccine. Clin Vaccine Immunol 2007 Sep;14(9):1235-8 [Abstract]
Byrne WR, Welkos SL, Pitt ML. Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother 1998;39:2153-4
Calhoun LN, Kwon YM. Salmonella-based plague vaccines for bioterrorism. J Microbiol Immunol Infect 2006 Apr;39(2):92-7 [Abstract]
Casman EA, Fischhoff B. Risk communication planning for the aftermath of a plague bioattack. Risk Analysis 2008 Oct;28(5):1327-42 [Abstract]
CDC. Fatal human plague: Arizona and Colorado, 1996. MMWR 1997;46(27):617-20 [Full text]
CDC. Human plague—United States, 1993-1994. MMWR 1994;43(13):242-6 [Full text]
CDC. Human plague--four states, 2006. MMWR 2006 Aug 25;55(Dispatch):1-3 [Full text]
CDC. Imported plague: New York City, 2002. MMWR 2003 Aug 8;52(31):725-8 [Full text]
CDC. Plague pneumonia?California. MMWR 1984;33(34):481-3 [Full text]
CDC/ASM/APHL. Basic protocols for level A laboratories: for the presumptive identification of Yersinia pestis. Apr 2, 2002 [Full text]
Chain PSG, Carniel E, Larimer FW, et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci 2004 Sep 21;101(38):13826-31 [Abstract]
Chalton DA, Musson JA, Flick-Smith H, et al. Immunogenicity of a Yersinia pestis vaccine antigen monomerized by circular permutation. Infect Immun 2006 Dec;74(12):6624-31 [Abstract]
Chanteau S, Rahalison L, Ralafiarisoa L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 2003 Jan 18;361(9353):211-6 [Abstract]
Chanteau S, Rahalison L, Ratsitorahina M, et al. Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick. Int J Med Microbiol 2000;290(3):279-83 [Abstract]
Cleri DJ, Vernaleo JR, Lombardi LJ, et al. Plague pneumonia disease caused by Yersinia pestis. Semin Respir Infect 1997;12(1):12-23 [Abstract]
Cornelius CA, Quenee LE, Overheim KA, et al. Immunization with recombinant V10 protects Cynomolgus macaques from lethal pneumonic plague. Infect Immun 2008 (published online Sep 15) [Abstract]
Crook LD, Tempest B. Plague: a clinical review of 27 cases. Arch Intern Med 1992;152(6):1253-6 [Abstract]
Cunha BA. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Clin Microbiol Rev 2002 Aug 8(8):489-503 [Abstract]
Drancourt M, Aboudharam G, Signoli M, et al. Detection of 400-year-old Yersinia pestis DNA in human dental pulp: an approach to the diagnosis of ancient septicemia. Proc Natl Acad Sci 1998 Oct 13;95(21):12637-40 [Full text]
Drancourt M, Houhamdi L, Raoult D. Yersinia pestis as a telluric, human ectoparasite-borne organism. Lancet Infect Dis 2006 Apr;6(4):234-4 [Abstract]
Drancourt M, Roux V, Dang LV, et al. Genotyping, orientalis-like Yersinia pestis, and plague pandemics. Emerg Infect Dis 2004 Sep;10(9):1585-92 [Full text]
Drancourt M, Signoli M, Dang LV, et al. Yersinia pestis Orientalis in remains of ancient plague patients. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 23) [Full text]
DuBois AB, Freytag LC, Clements JD. Evaluation of combinatorial vaccines against anthrax and plague in a murine model. Vaccine 2007 Jun 11;25(24):4747-54 [Abstract]
Eidson M, Tierney LA, Rollag OJ, et al. Feline plague in New Mexico: risk factors and transmission to humans. Am J Public Health 1988;78(10):1333-5
Eisen RJ, Bearden SW, Wilder AP, et al. Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics. Proc Natl Acad Sci 2006 (published online Oct 10) [Abstract]
Eisen RJ, Borchert JN, Holmes JL, et al. Early-phase transmission of Yersinia pestis by cat fleas (Ctenocephalides felis) and their potential role as vectors in a plague-endemic region of Uganda. Am J Trop Med Hyg 2008 Jun;78(6):949-56 [Abstract]
Eisen RJ, Petersen JM, Higgins CL, et al. Persistence of Yersinia pestis in soil under natural conditions. Emerg Infect Dis 2008 Jun;14(6):941-3 [Abstract]
Eisen RJ, Reynolds PJ, Ettestad P. et al. Residence-linked human plague in New Mexico: a habitat-suitability model. Am J Trop Med Hyg 2007 Jul;77(1):121-5 [Abstract]
Elvin SJ, Eyles JE, Howard KA, et al. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine 2005 Dec 21 [Full text]
Eyles JE, Butcher WA, Titball RW, et al. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Vaccine 2007 Oct 16;25(42):7301-6 [Abstract]
Forman S, Wulff CR, Myers-Morales T, et al. yadBC of Yersinia pestis, a new virulence determinant for bubonic plague. Infect Immun 2008 Feb;76(2):578-87 [Abstract]
Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278(5):399-411 [Abstract]
Frean J, Klugman KP, Arntzen L, et al. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents. J Antimicrob Chemother 2003 Aug;52(2):294-6 [Abstract]
Frean JA, Arntzen L, Capper T, et al. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob Agents Chemother 1996;40(11):2646-7 [Full text]
Gabastou JM, Proano J, Vimos A, et al. An outbreak of plague including cases with probable pneumonic infection, Ecuador, 1998. Trans R Soc Trop Med Hyg 2000;94(4):387-91 [Abstract]
Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated human plague in the Western US, 1977-1998. Clin Infect Dis 2000 Jun;30(6):893-900 [Abstract]
Galimand M, Guiyoule A, Gerbaud G, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 1997;337(10):677-80 [Full text]
Galvan EM, Chen H, Schifferli DM. The Psa fimbriae of Yersinia pestis interact with phosphatidylcholine on alveolar epithelial cells and pulmonary surfactant. Infect Immun 2007 Mar;75(3):1272-9 [Abstract]
Gani R, Leach S. Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerg Infect Dis 2004 Apr;10(4):608-14 [Full text]
Gould LH, Pape J, Ettestad P, et al. Dog-associated risk factors for human plague. Zoonoses Public Health 2008 (published online May 16) [Abstract]
Gradon JD. Plague pneumonia. Curr Infect Dis Rep 2002 Jun;4(3):244-8 [Abstract]
Grosfeld H, Cohen S, Bino T, et al. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect Immun 2003 Jan:71(1):374-83 [Full text]
Guarner J, Shieh WJ, Greer PW, et al. Immunohistochemical detection of Yersinia pestis in formalin-fixed, paraffin-embedded tissue. Am J Clin Pathol 2002;117(2):205-9 [Abstract]
Guiyoule A, Rasoamanana B, Buchrieser C, et al. Recent emergence of new variants of Yersinia pestis in Madagascar. J Clin Microbiol 1997;35(11):2826-33 [Full text]
Gupta ML, Sharma A. Pneumonic plague, northern India, 2002. (Letter) Emerg Infect Dis 2007 Apr;13(4) (published online Mar 8) [Full text]
Heath DG, Anderson GW, Mauro JM, et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1998;16(11-12):1131-7 [Abstract]
Heine HS, Louie A, Sorgel F, et al. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. J Infect Dis 2007 Sep 1;196(5):782-7 [Abstract]
Hill J, Eyles JE, Elvin SJ, et al. Administration of antibody to the lung protects mice against pneumonic plague. Infect Immunol 2006 May;74(5):3068-70 [Abstract]
Hinnebusch BJ, Rudolph AE, Cherepanov P, et al. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science 2002 Apr 26;296(5568):733-5 [Abstract]
Hinnebusch BJ. Transmission factors: Yersinia pestis genes required to infect the flea vector of plague. Adv Exp Med Biol 2003;529:55-62
Houhamdi L, Lepidi H, Drancourt M, et al. Experimental model to evaluate the human body louse as a vector of plague. J Infect Dis 2006;194((11):1589-96 [Abstract]
Huang XZ, Chu MC, Engelthaler DM, et al. Genotyping of a homogeneous group of Yersinia pestis strains isolated in the United States. J Clin Microbiol 2002 Apr;40(4):1164-73 [Abstract]
Hull HR, Montes JM, Mann JM. Septicemic plague in New Mexico. J Infect Dis 1987;155(1):113-8 [Abstract]
Inglesby T, Grossman R, O'Toole T. A plague war on your city: observations from TOPOFF. Clin Infect Dis 2001 Feb 1; 32(3):436-45 [Full text]
Inglesby TV, Dennis DT, Henderson DA, et al, for the Working Group on Civilian Biodefense. Plague as a biological weapon: medical and public health management. JAMA 2000;283(17):2281-90 [Full text]
Jarrett CO, Deak E, Isherwood KE, et al. Transmission of Yersinia pestis from an infectious biofilm in the flea vector. J Infect Dis 2004 Aug 15;190(4):783-92 [Abstract]
Jarrett CO, Sebbane F, Adamovicz JJ, et al. Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague. Infect Immun 2004 Apr;72(4):2052-6 [Abstract]
Jones SM, Griffin KF, Hodgson I, et al. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 2003 Sep 8;21(25-26):3912-8 [Abstract]
Kausrud KL, Viljugrein H, Frigessi A, et al. Climatically driven synchrony of gerbil populations allows large-scale plague outbreaks. Proc Biol Soc 2007 Aug 22;274(1621):1963-9 [Abstract]
Kim W, Song MO, Song W, et al. Comparison of 16S rDNA analysis and rep-PCR genomic fingerprinting for molecular identification of Yersinia pseudotuberculosis. Antonie Van Leeuwenhoek. 2003;83(2):125-33 [Abstract]
Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 2005 Apr 15;40(8):1166-72 [Abstract]
Kuberski T, Robinson L, Schurgin A. A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene. Clin Infect Dis 2003 Feb 15;36(4):521-3 [Abstract]
Lathem WW, Price PA, Miller VL, et al. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 2007 Jan 26;315(5811):509-13 [Abstract]
Laudisoit A, Leirs H, Makundi RH, et al. Plague and the human flea, Tanzania. Emerg Infect Dis 2007 May;13(5) (published online Apr 4) [Full text]
Li B, Guo Y, Guo Z, et al. Serologic survey of the sentinel animals for plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray. Am J Trop Med Hyg 2008 Nov;79(5):799-802 [Abstract]
Li B, Jiang L, Song Q, et al. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect Immun 2005 Jun 1;73(6):3734-9 [Abstract]
Li M, Song Y, Li B, et al. Asymptomatic Yersinia pestis infection, China. (Letter) Emerg Infect Dis 2005 Sep;11(9) [Full text]
Lindler LE, Fan W, Jahan N. Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler. J Clin Microbiol 2001;39(10):3649-55 [Full text]
Liu WT, Hsu HL, Liang CC, et al. A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen. FEMS Immunol Med Microbiol 2007 (published online Jul 19) [Abstract]
Lorange EA, Race BL, Sebbane F, et al. Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis. J Infect Dis 2005 Jun 1;191(11):1907-12 [Abstract]
Louie A, Deziel MR, Liu W, et al. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy. Antimicrob Agents Chemother 2007 Aug;51(8):2661-7 [Abstract]
Lukaszewski RA, Kenny DJ, Taylor R, et al. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophage and neutrophils. Infect Immun 2005 Nov;73(11):7142-50 [Abstract]
Mangold T, Goldberg J. Plague wars: a true story of biological warfare. New York: St. Martin's Press, 1999
Margolis DA, Burns J, Reed SL, et al. Septicemic plague in a community hospital in California. Am J Trop Med Hyg 2008 Jun;78(6):868-71 [Abstract]
Marketon MM, DePaolo RW, DeBord KL, et al. Plague bacteria target immune cells during infection. Science 2005 (published online Jul 28) [Abstract]
Massin L, Legrand J, Valleron AJ, et al. Modelling outbreak control for pneumonic plague. Epidemiol Infect 2006 (Epub ahead of print Nov 23) [Abstract]
McGovern TW, Christopher GW, Eitzen EM. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol 1999;135(3):311-22 [Abstract]
McGovern TW, Friedlander AM. Plague. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Chap 23. Washington, DC: Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center. [Full text]
Mett V, Lyons J, Musiychuk K, et al. A plant-based plague vaccine candidate confers protection to monkeys. Vaccine 2007 Apr 20;25(16):3014-7 [Abstract]
Mizel SB, Graff AH, Sriranganathan N, et al. A fusion protein, flagellin/F1/V, is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol 2008 (published online Nov 5) [Abstract]
Morefield GL, Tammariello RF, Purcell BK, et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague, and staphylococcal toxic shock. J Immune Based Ther Vaccines 2008 Sep 3;6(1):5 [Abstract - with link to full text article]
Morris SR. Development of a recombinant vaccine against aerosolized plague. Vaccine 2007 Apr 20;25(16):3115-7 [Abstract]
Murray BE, Anderson KE, Arnold K, et al. Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary? (Viewpoints) Clin Infect Dis 2005 Jun 1;40(11):1644-8 [Abstract]
Mwengee W, Butler T, Mgema S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 2005 Mar 1;42(5):614-21 [Full text]
Neerinckx S, Peterson AT, Gulinck H, et al. Geographic distribution and ecological niche of plague in sub-Saharan Africa. Int J Health Geogr 2008;7:54 (published online Oct 23) [Abstract]
Niska RW, Burt CW. Training for terrorism-related conditions in hospitals: United States, 2003-04. Adv Data 2006 Dec 11;(380):1-9 [Full text]
O'Brien KK, Higdon NL, Halverson JJ. Recognition and management of bioterrorism infections. Am Fam Physician 2003 May 1;67(9):1927-34 [Full text]
Orloski KA, Lathrop SL. Plague: a veterinary perspective. J Am Vet Med Assoc 2003 Feb 15;222(4):444-8
Overheim KA, DePaolo RW, DeBord KL, et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 2005 Aug;73(8):5152-9 [Abstract]
Palmer DL, Kisch AL, Williams RC Jr, et al. Clinical features of plague in the United States: the 1969-1970 epidemic. J Infect Dis 1971;124(4):367-71
Parent MA, Berggren KN, Kummer LW, et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 2005 Nov;73(11):7304-10 [Abstract]
Park H, Teja K, O'Shea JJ, et al. The Yersinia effector protein YpkA induces apoptosis independently of actin depolymerization. J Immunol 2007 May 15;178(10):6426-34 [Abstract]
Parkhill J, Wren BW, Thomson NR, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001 Oct 4;413(6855):523-7 [Abstract]
Parrino J, Hotchkiss RS, Bray M. Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 23) [Full text]
Perry RD, Fetherston JD. Yersina pestis--etiologic agent of plague. Clin Microbiol Rev 1997;10(1):35-66 [Full text]
Philipovskiy AV, Smiley ST. Vaccination with live Yersina pestis primes CD4 and CD8 cells that synergistically protect against lethal pulmonary Y pestis infection. Infect Immun 2007 Feb;75(2):878-85 [Abstract]
Radnedge L, Agron PG, Worsham PL, et al. Genome plasticity in Yersinia pestis. Microbiology 2002 Jun;148(Pt 6):1687-98 [Full text]
Ratsitorahina M, Chanteau S, Rahalison, et al. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 2000;355(9198):111-3 [Abstract]
Reed DS, Martinez MJ. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague. Vaccine 2006 Mar 20;24(13):2283-9 [Full text]
Revazishvili T, Rajanna C, Bakanidze L, et al. Characterization of Yersinia pestis isolates from natural foci of plague in the Republic of Georgia and their relationship to Y pestis isolates from other countries. Clin Microbiol Infect 2008 (published online Feb 21) [Abstract]
Rose LJ, Donlan R, Banerjee SN, et al. Survival of Yersinia pestis on environmental surfaces. Appl Environ Microbiol. 2003 Apr;69(4):2166-71 [Abstract]
Russell P, Eley SM, Bell DL, et al. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Y pestis infection in mice. J Antimicrob Chemother 1996;37:769-74 [Abstract]
Saikh KU, Kissner TL, Dyas B, et al. Human cytolytic T cell recognition of Yersinia pestis virulence proteins that target innate immune responses. J Infect Dis 2006 Dec 15;194(12):1753-60 (published online Nov 2) [Abstract]
Sebbane F, Jarrett CO, Gardner D, et al. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci 2026 Apr 4;104(4):5526-30 [Full text]
Sebbane F, Lamaitre N, Sturdevant DE, et al. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc Natl Acad Sci 2006 (published online Jul 24) [Abstract]
Sewell DL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol 2003 Jul;41(7):2801-9 [Abstract]
Shah PM. Ciprofloxacin prophylaxis and therapy of Yersinia pestis infection. J Antimicrob Chemother 1998;42(3):399
Smiley ST. Immune defense against pneumonic plague. Immunol Rev 2008 Oct;225(1):256-71 [Abstract]
Smith MD, Vinh DX, Nguyen TT, et al. In vitro antimicrobial susceptibilities of strains of Yersinia pestis. Antimicrob Agents Chemother 1995;39(9):2153-4 [Full text]
Splettstoesser WD, Grunow R, Rahalison L, et al. Serodiagnosis of human plague by a combination of immunomagnetic separation and flow cytometry. Cytometry 2003 Jun;53A(2):88-96 [Abstract]
Stenseth NC, Atshabar BB, Begon M, et al. Plague: past, present, and future. PLoS Med 2008 Jan 15;5(1):e3 [Full text]
Stenseth NC, Samia NI, Viljugrein H, et al. Plague dynamics are driven by climate. Proc Natl Acad Sci 2006 Published online Aug 21 [Abstract]
Titball RW, Hill J, Lawton DG, et al. Yersinia pestis and plague. Biochem Soc Trans 2003 Feb;31(Pt 1):104-7 [Abstract]
Titball RW, Leary SE. Plague. Br Med Bull 1998;54(3):625-33 [Abstract]
Titball RW, Williamson ED. Second and third generation plague vaccines. Adv Exp Med Biol 2003;529:397-406
Titball RW, Williamson ED. Vaccination against bubonic and pneumonic plague. Vaccine 2001;19(30):4175-84 [Abstract]
Tomaso H, Jacob D, Eickhoff M, et al. Preliminary validation of real-time PCR assays for the identification of Yersinia pestis. Clin Chem Lab Med 2008 Sep;46(9):1239-44 [Abstract]
Tomaso H, Thullier P, Seibold E, et al. Comparison of hand-held test kits, immunofluorescence microscopy, enzyme-linked immunosorbent assay, and flow cytometric analysis for rapid presumptive identification of Yersinia pestis. J Clin Microbiol 2007 Oct;45(10):3404-7 [Abstract]
Touchman JW, Wagner DM, Hao J, et al. A North American Yersinia pestis draft genome sequence: SNPs and phylogentic analysis. PLoS One 2007 Feb 21;2(2):e220 [Full text]
Velan B, Bar-Haim E, Zauberman A, et al. Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect Immun 2006 Nov;74(11):6365-76 [Abstract]
Webb CT, Brooks CP, Gage LK, et al. Classic flea-borne transmission does not drive plague epizootics in prairie dogs. Proc Natl Acad Sci 2006 Apr 18;103(16):6236-41 [Abstract]
Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis 2001;32:446-56 [Abstract]
Welch TJ, Fricke WF, McDermott PF, et al. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2007 Mar;2(3):e309 [Full text]
Welkos S, Norris S, Adamovicz J. A modified caspase-3 assay correlates with immunity of nonhuman primates to infection by Yersinia pestis. Clin Vaccine Immunol 2008 (published online May 14) [Abstract]
Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona: a spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med 1985;142:641-6
Whitby M, Ruff TA, Street AC, et al. Biological agents as weapons 2: anthrax and plague. Med J Aust 2002 Jun 17;176(2):605-8 [Abstract]
WHO. Human plague in 2000 and 2001. Wkly Epidemiol Rec 2003 Apr 18;78(16):130-5
WHO. Plague manual: epidemiology, distribution, surveillance, and control [Full text]
Wilder AP, Eisen RJ, Bearden SW, et al. Oropsylla hirsuta (Siphonaptera: Ceratophyllidae) can support plague epizootics in black-tailed prairie dogs (Cynomys ludovicanus) by early-phase transmission of Yersinia pestis. Vector-Borne Zoonotic Dis 2008 Jun 1;8(3):359-68 [Abstract]
Williamson ED, Eley SM, Stagg AJ, et al. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 2000;19(4-5):566-71 [Abstract]
Williamson ED, Flick-Smith HC, LeButt C, et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 2005 Jun 1;73(6):3598-608 [Abstract]
Williamson ED, Stagg AJ, Eley SM, et al. Kinetics of the immune response to the (F1 + V) vaccine in models of bubonic and pneumonic plague. Vaccine 2007 Jan 22;25(6):1142-8 [Abstract]
Wu CJ, Jan JT, Chen CM, et al. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob Agents Chemother 2004 Jul;48(7):2693-6 [Abstract]
Yamanaka H, Hoyt T, Yang X, et al. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against penumonic plague. Infect Immun 2008 Oct;76(10):4564-73 [Abstract]
Zauberman A, Cohen S, Levy Y, et al. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Vaccine 2008 Mar 20;26(13):1616-25 [Abstract]
|
